JP2014509298A5 - - Google Patents

Download PDF

Info

Publication number
JP2014509298A5
JP2014509298A5 JP2013539024A JP2013539024A JP2014509298A5 JP 2014509298 A5 JP2014509298 A5 JP 2014509298A5 JP 2013539024 A JP2013539024 A JP 2013539024A JP 2013539024 A JP2013539024 A JP 2013539024A JP 2014509298 A5 JP2014509298 A5 JP 2014509298A5
Authority
JP
Japan
Prior art keywords
optionally substituted
methyl
substituted
pyrazino
ylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013539024A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014509298A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2012/055489 external-priority patent/WO2012115286A1/en
Publication of JP2014509298A publication Critical patent/JP2014509298A/ja
Publication of JP2014509298A5 publication Critical patent/JP2014509298A5/ja
Pending legal-status Critical Current

Links

JP2013539024A 2011-02-25 2012-02-27 アルファへリックスミメティック及びその関連の方法 Pending JP2014509298A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161446801P 2011-02-25 2011-02-25
US61/446,801 2011-02-25
PCT/JP2012/055489 WO2012115286A1 (en) 2011-02-25 2012-02-27 Alpha helix mimetics and methods relating thereto

Publications (2)

Publication Number Publication Date
JP2014509298A JP2014509298A (ja) 2014-04-17
JP2014509298A5 true JP2014509298A5 (https=) 2015-05-07

Family

ID=45878996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013539024A Pending JP2014509298A (ja) 2011-02-25 2012-02-27 アルファへリックスミメティック及びその関連の方法

Country Status (5)

Country Link
US (1) US20140051706A1 (https=)
EP (1) EP2678341A1 (https=)
JP (1) JP2014509298A (https=)
CN (1) CN103517904A (https=)
WO (1) WO2012115286A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102168006B1 (ko) * 2010-10-07 2020-10-20 유니버시티 오브 써던 캘리포니아 체세포 줄기 세포의 비대칭 분열을 향상시키기 위한 cbp/카테닌 길항제
KR102077871B1 (ko) * 2010-11-16 2020-02-14 유니버시티 오브 써던 캘리포니아 체세포 줄기 세포의 비대칭 분열을 향상시키기 위한 cbp/카테닌 길항제
HK1201061A1 (en) * 2011-10-07 2015-08-21 University Of Southern California Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
US20150274751A1 (en) * 2012-10-19 2015-10-01 Prism Pharma Co., Ltd. Treatment of scleroderma using an inhibitor of cbp/catenin
CN104902901A (zh) * 2012-10-19 2015-09-09 株式会社棱镜制药 使用cbp/连环蛋白的抑制剂治疗过度增殖性和癌前皮肤病
JP6303112B2 (ja) 2012-12-12 2018-04-04 株式会社PRISM Pharma 肝線維症の予防または治療剤
WO2015056104A2 (en) * 2013-10-18 2015-04-23 Hiroyuki Kouji Treatment of hepatic fibrosis using an inhibitor of cbp/catenin
US9174998B2 (en) * 2013-12-25 2015-11-03 Eisai R&D Management Co., Ltd. (6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-2-(prop-2-en-1-yl)-octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide compound
BR112017027227B1 (pt) * 2015-06-16 2023-12-12 Eisai R&D Management Co., Ltd Agente anti-câncer
CA2986999C (en) 2015-06-23 2023-08-08 Eisai R&D Management Co., Ltd. Crystal of (6s,9as)-n-benzyl-8-({6-[3-(4-ethylpiperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-6-(2-fluoro-4-hydroxybenzyl)-4,7-dioxo-2-(prop-2-en-1-yl)hexahydro-2h-pyrazino[2,1-c][1,2,4]triazine-1(6h)-carboxamide
CN105061315B (zh) * 2015-08-06 2017-10-24 大连理工大学 一类1,5‑二苯基吡唑‑3‑羧酸类化合物及其应用
WO2017047762A1 (ja) * 2015-09-18 2017-03-23 国立大学法人鳥取大学 低分子化合物による癌と線維化の抑制と再生促進の効果
JP6581320B2 (ja) 2017-02-08 2019-09-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍治療用医薬組成物
EP3624800A4 (en) 2017-05-16 2021-02-17 Eisai R&D Management Co., Ltd. TREATMENT OF HEPATOCELLULAR CARCINOMA
MX2022005056A (es) 2019-10-29 2022-05-18 Eisai R&D Man Co Ltd Combinacion de un antagonista de pd-1, un inhibidor tirosina cinasa de vegfr/fgfr/ret y un inhibidor de cbp/beta-catenina para el tratamiento del cancer.
WO2021183791A1 (en) * 2020-03-12 2021-09-16 City Of Hope Wnt/cbp/catenin signaling pathway inhibitors and uses thereof
AR121544A1 (es) 2020-03-12 2022-06-15 3 2 Pharma Inhibidores de la vía de señalización por cbp / catenina y sus usos
CN116018345A (zh) * 2020-07-16 2023-04-25 株式会社棱镜生物实验室 新的杂环化合物
CN116925081A (zh) * 2022-04-11 2023-10-24 中国科学院上海药物研究所 一种环肽类化合物及其应用
TW202408503A (zh) * 2022-05-04 2024-03-01 美商雅斯娜製藥公司 治療纖維化之方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
WO1992013878A2 (en) 1991-02-07 1992-08-20 Board Of Trustees Of The University Of Illinois Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
WO1994003494A1 (en) 1992-08-06 1994-02-17 The Board Of Trustees Of The University Of Illinois Conformationally restricted mimetics of reverse turns and peptides containing the same
US6013458A (en) 1995-10-27 2000-01-11 Molecumetics, Ltd. Reverse-turn mimetics and methods relating thereto
US5929237A (en) 1995-10-27 1999-07-27 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
US6184223B1 (en) 1995-10-27 2001-02-06 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
US6117445A (en) * 1998-01-28 2000-09-12 Link Technology Inc. Methods for the prevention and treatment of fibrosis and sclerosis
US6410245B1 (en) 1998-04-01 2002-06-25 Affymax, Inc. Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
US6294525B1 (en) 1999-09-01 2001-09-25 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
DE20119322U1 (de) 2000-11-21 2002-02-21 Schering Ag, 13353 Berlin Röhrenförmige Gefäßimplantate (Stents)
EP1444235B1 (en) * 2001-10-12 2008-06-11 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7576084B2 (en) * 2001-10-12 2009-08-18 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7671054B1 (en) * 2001-10-12 2010-03-02 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
CA2502644A1 (en) * 2002-10-17 2004-04-29 Myriad Genetics, Inc. Reverse-turn mimetics and composition and methods relating thereto
EP1660502A2 (en) * 2003-08-28 2006-05-31 Choongwae Pharma Corporation MODULATION OF ß-CATENIN/TCF ACTIVATED TRANSCRIPTION
EP1804838A2 (en) * 2004-09-15 2007-07-11 Drug Discovery Laboratory AS Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs
WO2007056513A1 (en) 2005-11-08 2007-05-18 Institute For Chemical Genomics α-HELIX MIMETICS AND METHODS RELATING TO THE TREATMENT OF FIBROTIC DISORDERS
KR101486490B1 (ko) 2005-11-08 2015-01-27 제이더블유중외제약 주식회사 α-헬릭스 유사체 및 암 줄기세포의 치료에 관한 방법
WO2009148192A1 (en) 2008-06-06 2009-12-10 Prism Biolab Corporation Alpha helix mimetics and methods relating thereto
CN102186853A (zh) 2008-10-14 2011-09-14 株式会社棱镜生物实验室 治疗癌症α-螺旋模拟物
ES2578990T3 (es) * 2009-03-21 2016-08-03 Sunshine Lake Pharma Co., Ltd. Derivados de amino éster, sales de los mismos y métodos de uso
CN102459271B (zh) * 2009-04-15 2014-07-02 Jw制药公司 回折模拟物的新化合物及其制备方法和用途
US9040531B2 (en) 2009-05-07 2015-05-26 Prism BioLab Co., Ltd. Alpha helix mimetics and methods relating thereto

Similar Documents

Publication Publication Date Title
JP2014509298A5 (https=)
RU2010154114A (ru) Альфа-спиральные миметики и способы, связанные с ними
US10766914B2 (en) DNA alkylating agents
JP2008505117A5 (https=)
JP2013545810A5 (https=)
JP2020535168A5 (https=)
JP2010516635A5 (https=)
CA2549401A1 (en) Heterocyclic anti-migraine agents
JP2010280684A5 (https=)
TWI905255B (zh) 新型Rho相關蛋白激酶抑制劑的製備方法和此製備方法中的中間體
JP2008512379A (ja) 置換2−(2,6−ジオキソピペリジン−3−イル)−1−オキソイソインドリン類の調製方法
EP0693478A1 (en) Quinoline compounds
JP2011510929A5 (https=)
HRP20151336T1 (hr) Tetrahidroizokinolin-1-on derivat ili njegova sol
JP2014521620A5 (https=)
JPS5921862B2 (ja) エステル化法
HU199418B (en) Process for producing new, substituted anilide derivatives
JP2006519807A5 (https=)
JP2005508292A5 (https=)
JP2010526142A5 (https=)
RU2003131966A (ru) Производные 4-(фенил-(пиперидин-4-ил)-амино)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств
US20180065985A1 (en) Process for making tetracyclic heterocycle compounds
JP2005508290A5 (https=)
ES2349455T3 (es) Procedimiento para la preparación de ariletanoldiaminas útiles como agonistas del beta-3-adrenoceptor.
CN107848968A (zh) 从乙醛酸制备内酰胺的方法